Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer
New research identifies the cholesterol synthesis enzyme DHCR24 as a driver of endometrial carcinoma progression and a potential prognostic biomarker ...
New research identifies the cholesterol synthesis enzyme DHCR24 as a driver of endometrial carcinoma progression and a potential prognostic biomarker ...
Scientists have engineered exosomes that use natural RNA-sorting motifs and Rab4-boosted production to deliver ferroptosis-inducing shRNAs directly to endometrial tumors.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine